Post-COVID-19 Chronic Fatigue Syndrome
Study Details
Study Description
Brief Summary
Fatigue is recognized as one of the most commonly presented long-term complaints in individuals previously infected with SARS-CoV-2.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Detailed Description
It has become increasingly clear that infected patients have symptoms not only in the acute phase, but also after recovery from the initial infection.
A recent meta-analysis including 4828 patients with post-COVID-19 showed that symptoms and post-acute sequelae of SARS-CoV-2 can persist weeks to months after the infection.
These patients who reported persistent symptoms have been termed "long haulers" or described as having long COVID, post-acute COVID-19, persistent COVID-19 symptoms, post COVID-19 manifestations, long-term COVID-19 effects, post-acute sequelae of COVID-19 (PASC), or post-COVID-19 syndrome.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Synthetic Vitamin B1 Synthetic Vitamin B1, 400 mg per day |
Drug: Synthetic Vitamin B1
Synthetic Vitamin B1 400 mg per day
|
No Intervention: No intervention No intervention |
Outcome Measures
Primary Outcome Measures
- Fatigue scale [one month]
chalder fatigue scale
- Fatigue scale [two month]
chalder fatigue scale
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age . 18
-
Male or female
-
Post-Covid-19 Fatigue
Exclusion Criteria:
- refusal
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Asalam | Maadi | Cairo | Egypt | 11433 |
Sponsors and Collaborators
- ClinAmygate
- As-Salam Center, Maadi, Cairo, Egypt
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- PR0012022